2018
DOI: 10.1590/2177-9465-ean-2017-0440
|View full text |Cite
|
Sign up to set email alerts
|

Metacognition as an educational technology in self-care learning: the case of prevention of post-surgical lymphedema of breast cancer

Abstract: Aim: To introduce metacognition as an educational technology for learning self-care. In order to achieve this goal, it discusses the prevention of lymphedema after breast cancer surgery. Method: Reflexion paper based on philosophical and theoretical reasoning in adition of empirical evidence to support the use of metacognition for self care learnig. It states that using metacognitive resources as educational technology may promote more effective both teaching-learning process, stimulates critical and reflexiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…59 Metacognition has also been used as a strategy for improving executive function in patients who underwent chemotherapy 48 and can be used as an education tool to promote self-care practices in patients with breast cancer. 49…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…59 Metacognition has also been used as a strategy for improving executive function in patients who underwent chemotherapy 48 and can be used as an education tool to promote self-care practices in patients with breast cancer. 49…”
Section: Discussionmentioning
confidence: 99%
“…59 Metacognition has also been used as a strategy for improving executive function in patients who underwent chemotherapy 48 and can be used as an education tool to promote self-care practices in patients with breast cancer. 49 It was also noted that studies included for review used MCQ-30 as a tool to assess metacognitive beliefs in patients with cancer. A study validated the scale in 2014 for use among patients patients diagnosed with breast and prostate cancer, limiting its use across different cancer diagnoses.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation